Informing MS patients on treatment options: a consensus on the process of consent taking
- Tortorella C.
- Solaro C.
- Annovazzi P.
- Boffa L.
- Buscarinu M. C.
- Buttari F.
- Calabrese M.
- Cavalla P.
- Cocco E.
- Cordioli C.
- De Luca G.
- Di Filippo M.
- Fantozzi R.
- Ferraro D.
- Gajofatto A.
- Gallo A.
- Lanzillo R.
- Laroni A.
- Fermo S. L.
- Malucchi S.
- Maniscalco G. T.
- Moccia M.
- Nociti V.
- Paolicelli D.
- Pesci I.
- Prosperini L.
- Ragonese P.
- Tomassini V.
- Clerici V. L. A. T.
- Rodegher M.
- Gherardi M.
- Gasperini C.
DOIAbstract
Abstract: In the last years, change in multiple sclerosis (MS) therapeutic scenario has highlighted the need for an improved doctor-patient communication in advance of treatment initiation in order to allow patient’s empowerment in the decision-making process. Aims: The aims of our project were to review the strategies used by Italian MS specialists to inform patients about treatment options and to design a multicentre shared document that homogenizes the information about disease-modifying treatment (DMTs) and the procedure of taking informed consent in clinical practice. Results: The new resource, obtained by consensus among 31 neurologists from 27 MS Centres in Italy with the supervision of a medico-legal advisor, received the aegis of I...
Add to ORKG